![Danaher Corporation Strengthens Diagnostics Offerings with $4B Acquisition of Cepheid](https://evolution-bio.com/wp-content/uploads/2016/09/160907-danaher-cepheid-bio.jpg)
Danaher Corporation has announced the acquisition of medical diagnostics company Cepheid, strengthening their presence in the Molecular Diagnostics market. Danaher will pay $53 per share in cash, a premium of
![Pfizer to Buy Medivation for $14 Billion, But Who Are the Real Winners?](https://evolution-bio.com/wp-content/uploads/2016/08/160822-pfizer-medivation-bio.jpg)
Pharmaceutical giants Pfizer are expanding their cancer portfolio through the $14B acquisition of California-based biopharmaceutical company Medivation. The acquisition follows two recent unsuccessful bids for Medivation by Sanofi, as well